NCRI Press Release, 8 November 2010
Test selects 60 per cent of women with inherited ovarian cancer who could benefit from ‘smart’ drug
Download the attachment
Recent Tweets
-
@Chr_Stelios @TheBACR Congratulations Stelios!
2 days ago -
RT @amanimahbub : I highly recommend all the Cancer researchers to attend @NCRI_partners conference annually✨ you will learn a lot & update…
3 days ago -
RT @Chr_Stelios : Honoured to have received @TheBACR Hamilton Fairley Award @NCRI_partners #NCRI2018. https://t.co/LPS5WfHVBD
3 days ago
What's Happening
- 7 Nov 2018NCRI Screening Prevention & Early Diagnosis (SPED) Workshop – 9 January 2019: Call for proposals
- 30 Oct 2018NCRI recruiting for Events Marketing Manager (maternity cover)
- 9 Oct 2018NCRI’s Chairs’ Forum round-up: latest on our work to accelerate cancer research
- 25 Jul 2018Redesigning clinical research to improve outcomes for older people
- 18 May 2018NCRI Consumer Membership Applications to the CSGs - Closing Soon!
- 3 May 2018Dr Iain Frame appointed NCRI CEO
RSS Feed